Top Health Care Stocks
Health care stocks trimmed some of their prior declines Monday, including a nearly 0.4% decline for the NYSE Health Care Index in afternoon trade. Shares of health care companies in the S&P 500 also were down over 0.6% as a group while the Nasdaq Biotechnology index was down nearly 0.4%.
Among health care stocks moving on news:
(-) Abiomed ( ABMD ) declined over 7% after the US Food and Drug Administration Monday issued a letter warning health care providers it was evaluating new data suggesting a higher mortality rate for certain patients who received the company's Impella RP heart-assist pump implant compared with prior studies. But the agency also said while it was concerned by interim results from the post-approval study, it still believes the benefits of the heart-assist implant outweight the potential risk for patients experiencing severe heart problems.
In other sector news:
(+) BioLineRx ( BLRX ) soared as much as 21% on Monday after its BL-8040 lead oncology candidate to treat pancreatic cancer was designated as an Orphan Drug by the FDA.
(+) Omnicell ( OMCL ) was 3% higher on Monday after its automated drug dispensing device won a Best in KLAS award for the 13th year in a row from independent health care research firm KLAS based on ratings by industry professionals.
(-) AbbVie ( ABBV ) dropped over 3% on Monday after a new regulatory filing showed Blackrock ( BLK ) recently sold over 5.5 million shares of the drugmaker's stock, paring its passive stake to nearly 95.8 million AbbVie shares, or about 6.4% of its outstanding stock.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.